Phytic acid
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Phytic acid
- DrugBank Accession Number
- DB14981
- Background
Phytic acid is under investigation in clinical trial NCT01000233 (Value of Oral Phytate (InsP6) in the Prevention of Progression of the Cardiovascular Calcifications).
- Type
- Small Molecule
- Groups
- Investigational
- Structure
- Weight
- Average: 660.0353
Monoisotopic: 659.861370576 - Chemical Formula
- C6H18O24P6
- Synonyms
- 1D-myo-Inositol 1,2,3,4,5,6-hexakisphosphate
- 1D-myo-Inositol hexakisphosphate
- Acide fytique
- Acido fitico
- Acidum fyticum
- D-myo-Inositol 1,2,3,4,5,6-hexakisphosphate
- Fytic acid
- Inosithexaphosphorsäure
- Inositol hexaphosphate
- myo-inositol 1,2,3,4,5,6-hexakisphosphate
- myo-Inositol hexakisphosphate
- Phytate
- Phytine
- Säure des phytins
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 7IGF0S7R8I
- CAS number
- 83-86-3
- InChI Key
- IMQLKJBTEOYOSI-GPIVLXJGSA-N
- InChI
- InChI=1S/C6H18O24P6/c7-31(8,9)25-1-2(26-32(10,11)12)4(28-34(16,17)18)6(30-36(22,23)24)5(29-35(19,20)21)3(1)27-33(13,14)15/h1-6H,(H2,7,8,9)(H2,10,11,12)(H2,13,14,15)(H2,16,17,18)(H2,19,20,21)(H2,22,23,24)/t1-,2-,3-,4+,5-,6-
- IUPAC Name
- {[(1s,2R,3R,4r,5S,6S)-2,3,4,5,6-pentakis(phosphonooxy)cyclohexyl]oxy}phosphonic acid
- SMILES
- OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O
References
- General References
- Not Available
- External Links
- KEGG Compound
- C01204
- ChemSpider
- 16735966
- 8302
- ChEBI
- 17401
- ChEMBL
- CHEMBL1233511
- ZINC
- ZINC000169289809
- PDBe Ligand
- IHP
- Wikipedia
- Phytic_acid
- PDB Entries
- 1bq3 / 1dkp / 1dkq / 1hg5 / 1nih / 1thb / 1zsh / 1zy7 / 2fvv / 2k8r … show 197 more
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count 3 Completed Prevention Nutritional supplementation / Pregnancy 1 1 Completed Treatment Bipolar Disorder (BD) 1 Not Available Completed Basic Science Dental Decay 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 13.7 mg/mL ALOGPS logP 0.11 ALOGPS logP -4.5 Chemaxon logS -1.7 ALOGPS pKa (Strongest Acidic) 0.14 Chemaxon Physiological Charge -12 Chemaxon Hydrogen Acceptor Count 18 Chemaxon Hydrogen Donor Count 12 Chemaxon Polar Surface Area 400.56 Å2 Chemaxon Rotatable Bond Count 12 Chemaxon Refractivity 101.01 m3·mol-1 Chemaxon Polarizability 42.6 Å3 Chemaxon Number of Rings 1 Chemaxon Bioavailability 0 Chemaxon Rule of Five No Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 219.0473006 predictedDarkChem Lite v0.1.0 [M-H]- 172.42097 predictedDeepCCS 1.0 (2019) [M+H]+ 174.30307 predictedDeepCCS 1.0 (2019) [M+Na]+ 180.04349 predictedDeepCCS 1.0 (2019)
Drug created at May 20, 2019 14:39 / Updated at September 03, 2020 20:54